Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06915792 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy

Study acronym: PEACE
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jul 31, 2025 to Jul 31, 2027
    • Study sites: 0 to 1
    • Study completion date: Oct 31, 2025 to Oct 31, 2027
    • Start date changed from estimate of Apr 1, 2025 to Jun 1, 2025
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized controlled trial compares two common medications, labetalol and extended-release nifedipine, to determine which is more effective at managing postpartum high blood pressure. We hypothesize that extended-release nifedipine will better control blood pressure and reduce the need for continued medication beyond six weeks postpartum. The study will enroll 110 postpartum participants, randomly assigning them to one of the two medications, with remote blood pressure monitoring to evaluate treatment effectiveness and inform postpartum hypertension management.
Trial Details
NCT Number NCT06915792
Lead Sponsor University of California, Los Angeles
Conditions
(from sponsor)		 Postpartum Hypertension (PPHT)
Related terms Hypertension, Pregnancy-Induced
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov